The demand for glucagon-like peptide 1 (GLP-1) receptor agonists for overweight/obesity has created a clinical conundrum for ...

With obesity rates among children and teens climbing, pediatricians are using a variety of structured programs to help ...

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...

Scientists at Ohio University have identified a protein that could help fight obesity by improving metabolism and preventing ...

Adding an anti-obesity medication just one month after behavioral therapy begins-rather than waiting the currently recommended six months-can more than double weight loss for patients who struggle ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Obesity is a global health concern closely linked to a range of metabolic diseases, such as type 2 diabetes and ...

This study shows that the SAAR diet regulates glucose and lipid metabolism to support weight control without impacting ...

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...